475 related articles for article (PubMed ID: 19785838)
1. [Progress due to genetic research on rheumatoid arthritis: hype or hope?].
Jacobs JW; Huizinga TW; Bijlsma JW; van der Helm-van Mil AH
Ned Tijdschr Geneeskd; 2009; 153():A206. PubMed ID: 19785838
[TBL] [Abstract][Full Text] [Related]
2. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.
van der Linden MP; van der Woude D; Ioan-Facsinay A; Levarht EW; Stoeken-Rijsbergen G; Huizinga TW; Toes RE; van der Helm-van Mil AH
Arthritis Rheum; 2009 Aug; 60(8):2232-41. PubMed ID: 19644872
[TBL] [Abstract][Full Text] [Related]
3. The DERAA HLA-DR alleles in patients with early polyarthritis: protection against severe disease and lack of association with rheumatoid arthritis autoantibodies.
Carrier N; Cossette P; Daniel C; de Brum-Fernandes A; Liang P; Ménard HA; Boire G
Arthritis Rheum; 2009 Mar; 60(3):698-707. PubMed ID: 19248090
[TBL] [Abstract][Full Text] [Related]
4. Validation of a prediction rule for development of rheumatoid arthritis in patients with early undifferentiated arthritis.
Kuriya B; Cheng CK; Chen HM; Bykerk VP
Ann Rheum Dis; 2009 Sep; 68(9):1482-5. PubMed ID: 19015211
[TBL] [Abstract][Full Text] [Related]
5. Opposing effects of HLA-DRB1*13 alleles on the risk of developing anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis.
Lundström E; Källberg H; Smolnikova M; Ding B; Rönnelid J; Alfredsson L; Klareskog L; Padyukov L
Arthritis Rheum; 2009 Apr; 60(4):924-30. PubMed ID: 19333936
[TBL] [Abstract][Full Text] [Related]
6. Early inflammatory arthritis versus rheumatoid arthritis.
Finckh A
Curr Opin Rheumatol; 2009 Mar; 21(2):118-23. PubMed ID: 19339921
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of disease: Genetic susceptibility and environmental triggers in the development of rheumatoid arthritis.
Klareskog L; Padyukov L; Lorentzen J; Alfredsson L
Nat Clin Pract Rheumatol; 2006 Aug; 2(8):425-33. PubMed ID: 16932734
[TBL] [Abstract][Full Text] [Related]
8. Quantitative heritability of anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis.
van der Woude D; Houwing-Duistermaat JJ; Toes RE; Huizinga TW; Thomson W; Worthington J; van der Helm-van Mil AH; de Vries RR
Arthritis Rheum; 2009 Apr; 60(4):916-23. PubMed ID: 19333951
[TBL] [Abstract][Full Text] [Related]
9. [The clinical significance of cyclic citrullinated peptide antibodies: new data].
Novikov AA; Aleksandrova EN; Nasonov EL
Klin Med (Mosk); 2007; 85(8):4-9. PubMed ID: 17926481
[TBL] [Abstract][Full Text] [Related]
10. Early rheumatoid arthritis.
Scott DL
Br Med Bull; 2007; 81-82():97-114. PubMed ID: 17540693
[TBL] [Abstract][Full Text] [Related]
11. Anti-CCP2 is an adjunct to, not a surrogate for, rheumatoid factor in the diagnosis of rheumatoid arthritis: diagnostic utility of anti-CCP2 antibodies in Egyptian patients with rheumatoid arthritis.
Abdel-Nasser AM; Mahmoud MH; El Mansoury TM; Osman AM
Scand J Rheumatol; 2008; 37(5):329-36. PubMed ID: 18666028
[TBL] [Abstract][Full Text] [Related]
12. Choice of second-line disease-modifying antirheumatic drugs after failure of methotrexate therapy for rheumatoid arthritis: a decision tree for clinical practice based on rheumatologists' preferences.
Fautrel B; Guillemin F; Meyer O; de Bandt M; Berthelot JM; Flipo RM; Lioté F; Maillefert JF; Wendling D; Saraux A; Combe B; Le Loët X; ; ;
Arthritis Rheum; 2009 Apr; 61(4):425-34. PubMed ID: 19333993
[TBL] [Abstract][Full Text] [Related]
13. Current concepts in the genetic diagnostics of rheumatoid arthritis.
Nagy ZB; Csanád M; Tóth K; Börzsönyi B; Demendi C; Rigó J; Joó JG
Expert Rev Mol Diagn; 2010 Jul; 10(5):603-18. PubMed ID: 20629510
[TBL] [Abstract][Full Text] [Related]
14. Immunogenetic risks of anti-cyclical citrullinated peptide antibodies in a North American Native population with rheumatoid arthritis and their first-degree relatives.
El-Gabalawy HS; Robinson DB; Hart D; Elias B; Markland J; Peschken CA; Smolik I; Montes-Aldana G; Schroeder M; Fritzler MJ; Cheang M; Oen K
J Rheumatol; 2009 Jun; 36(6):1130-5. PubMed ID: 19411392
[TBL] [Abstract][Full Text] [Related]
15. Recent progress in rheumatoid arthritis genetics: one step towards improved patient care.
Plenge RM
Curr Opin Rheumatol; 2009 May; 21(3):262-71. PubMed ID: 19365266
[TBL] [Abstract][Full Text] [Related]
16. Personalized medicine in rheumatoid arthritis: hopes and challenges.
Bridges SL
Bull NYU Hosp Jt Dis; 2007; 65(3):174-7. PubMed ID: 17922665
[TBL] [Abstract][Full Text] [Related]
17. Familial disease, the HLA-DRB1 shared epitope and anti-CCP antibodies influence time at appearance of substantial joint damage in rheumatoid arthritis.
Rojas-Villarraga A; Diaz FJ; Calvo-Páramo E; Salazar JC; Iglesias-Gamarra A; Mantilla RD; Anaya JM
J Autoimmun; 2009 Feb; 32(1):64-9. PubMed ID: 19117726
[TBL] [Abstract][Full Text] [Related]
18. The role of anti-mutated citrullinated vimentin antibodies in the diagnosis of early rheumatoid arthritis.
Liu X; Jia R; Zhao J; Li Z
J Rheumatol; 2009 Jun; 36(6):1136-42. PubMed ID: 19447936
[TBL] [Abstract][Full Text] [Related]
19. Genetic differences between patients with rheumatoid arthritis.
Cojocaru M; Chicoş B
Rom J Intern Med; 2013; 51(2):89-91. PubMed ID: 24294811
[TBL] [Abstract][Full Text] [Related]
20. Genetic basis of rheumatoid arthritis.
Orozco G; Rueda B; Martin J
Biomed Pharmacother; 2006 Dec; 60(10):656-62. PubMed ID: 17055211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
